These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 16647884

  • 1. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy.
    Aikiä M, Jutila L, Salmenperä T, Mervaala E, Kälviäinen R.
    Epilepsy Behav; 2006 Jun; 8(4):750-5. PubMed ID: 16647884
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy.
    Kälviäinen R.
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
    Zhou B, Zhang Q, Tian L, Xiao J, Stefan H, Zhou D.
    Epilepsy Behav; 2008 Feb; 12(2):305-10. PubMed ID: 18024209
    [Abstract] [Full Text] [Related]

  • 7. Comparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study.
    Biraben A, Beaussart M, Josien E, Pestre M, Savet JF, Schaff JL, Tourniaire D, Sevestre M, Renault-Djouadi J.
    Epileptic Disord; 2001 Jun; 3(2):91-100. PubMed ID: 11431171
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tiagabine: new preparation. Refractory partial epilepsy: another alternative.
    Prescrire Int; 1998 Aug; 7(36):99-101. PubMed ID: 10342943
    [Abstract] [Full Text] [Related]

  • 10. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy.
    Kälviäinen R, Aikiä M, Mervaala E, Saukkonen AM, Pitkänen A, Riekkinen PJ.
    Epilepsy Res; 1996 Nov; 25(3):291-7. PubMed ID: 8956929
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of adjunctive therapy with tiagabine in mentally disabled patients with epilepsy.
    Chmielewska B, Stelmasiak Z.
    Ann Univ Mariae Curie Sklodowska Med; 2002 Nov; 57(1):226-36. PubMed ID: 12898928
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
    Kälviäinen R, Brodie MJ, Duncan J, Chadwick D, Edwards D, Lyby K.
    Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy.
    Wesnes KA, Edgar C, Dean AD, Wroe SJ.
    Epilepsy Behav; 2009 Mar; 14(3):522-8. PubMed ID: 19111629
    [Abstract] [Full Text] [Related]

  • 18. Tiagabine (gabitril) experience in children.
    Pellock JM.
    Epilepsia; 2001 Mar; 42 Suppl 3():49-51. PubMed ID: 11520324
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tiagabine for epilepsy.
    Med Lett Drugs Ther; 1998 Apr 10; 40(1024):45-6. PubMed ID: 9580745
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.